September 28, 2006 -- In a widely reported story, the New England Journal of Medicine recently put the kybosh on hopes that transplanting islets into diabetes patients would soon become standard treatment. As we pointed out earlier, islet transplantation would never become common, because it takes ten to twelve cadavers to produce enough cells to have a successful transplant. We look at the disappointing islet trial and the prospects for stem cells as a diabetes therapy...
